Concepedia

Blagoje Murganić

BM

5

Publications

88

Citations

5

H-Index

2017

Active since

Affiliations

Leipzig University(Current)

University of Belgrade

Helmholtz-Zentrum Dresden-Rossendorf

Goethe University Frankfurt

Institute for Biological Research “Siniša Stanković”

Blagoje Murganić is an author at Leipzig University specializing in medicinal chemistry, pharmacotherapy, and drug discovery.

ORCID

Top concepts

Publications per year

2017–2020

5

Publications

5

Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells

Antonio Buzharevski, Svetlana Paskaš, Menyhárt B. Sárosi et al. · Scientific Reports · 2020 · 21 citations · Full text

Carborane‐Based Analogues of 5‐Lipoxygenase Inhibitors Co‐inhibit Heat Shock Protein 90 in HCT116 Cells

Robert Kuhnert, Menyhárt B. Sárosi, Sven George et al. · ChemMedChem · 2018 · 19 citations

Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

Antonio Buzharevski, Svetlana Paskaš, Markus Laube et al. · ACS Omega · 2019 · 18 citations · Full text

, , +16

CarbORev‐5901: The First Carborane‐Based Inhibitor of the 5‐Lipoxygenase Pathway

Robert Kuhnert, Menyhárt B. Sárosi, Sven George et al. · ChemMedChem · 2017 · 17 citations

Quinoline‐Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action

Marta Gozzi, Blagoje Murganić, Dijana Drača et al. · ChemMedChem · 2019 · 13 citations · Full text

Rows per page

1–5 of 5